home / stock / cemi / cemi news

CEMI News and Press, Chembio Diagnostics Inc. From 05/07/19

Stock Information
Company Name: Chembio Diagnostics Inc.
Stock Symbol: CEMI
Market: NASDAQ
Website: chembio.com
Menu
CEMI CEMI Quote CEMI Short CEMI News CEMI Articles CEMI Message Board
Get CEMI Alerts

News, Short Squeeze, Breakout and More Instantly...
CEMI - Chembio Diagnostics Announces Approval of Dengue Point-of-Care Test by Brazil's Health Regulatory Agency

MEDFORD, N.Y., May 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the approval of its DPP Dengue System by Agência Nacional de Vigilância Sanitária (ANVISA), Br...
CEMI - Chembio Diagnostics, Inc. (CEMI) CEO John Sperzel on Q1 2019 Results - Earnings Call Transcript

Chembio Diagnostics, Inc. (CEMI) Q1 2019 Earnings Conference Call May 01, 2019, 16:30 ET Company Participants Philip Taylor - IR John Sperzel - President, CEO & Director Neil Goldman - EVP & CFO Conference Call Participants Kyle Bauser - Dougherty & Company Pe...

CEMI - Chembio Diagnostics misses by $0.01, misses on revenue

Chembio Diagnostics (NASDAQ: CEMI ): Q1 GAAP EPS of -$0.16 misses by $0.01 . More news on: Chembio Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

CEMI - Chembio Diagnostics Reports First Quarter 2019 Financial Results

MEDFORD, N.Y., May 01, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended March 31, 2019. Recent Accomplishments & Highlights Achiev...
CEMI - Chembio Diagnostics to Report First Quarter 2019 Financial Results on May 1, 2019

MEDFORD, N.Y., April 22, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the first quarter of 2019 after the close of trading on Wednesda...

CEMI - Chembio's zika, dengue and chikungunya multiplex test approved in Brazil

Agência Nacional de Vigilância Sanitária ((ANVISA)), Brazil’s health regulatory agency approves Chembio Diagnostics' (NASDAQ: CEMI ) DPP Zika/Dengue/Chikungunya System. More news on: Chembio Diagnostics, Inc., Healthcare stocks news, Stocks on the move, Read mor...

CEMI - Chembio Diagnostics Announces Approval of Zika, Dengue and Chikungunya Point-of-Care Multiplex Test by Brazil's Health Regulatory Agency

MEDFORD, N.Y., April 09, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the approval of its DPP Zika/Dengue/Chikungunya System by Agência Nacional de Vigilância Sanit&#x...
CEMI - Chembio Diagnostics Announces Agreement with Perseus Science to Advance Point-of-Care Concussion Test

MEDFORD, N.Y., April 02, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that the company has entered into an agreement with Perseus Science Group LLC, to advance the development o...

CEMI - Chembio Diagnostics, Inc. (CEMI) CEO John Sperzel on Q4 2018 Results - Earnings Call Transcript

Call Start: 16:30 Call End: 17:03 Chembio Diagnostics, Inc. (CEMI) Q4 2018 Earnings Conference Call March 7, 2019 04:30 PM ET Company Participants Philip Taylor - IR John Sperzel - President, CEO Neil Goldman - CFO Conference Call Participants Per Ostlund - Craig-Hallum...

CEMI - Chembio Diagnostics misses by $0.04, beats on revenue

Chembio Diagnostics (NASDAQ: CEMI ): Q4 GAAP EPS of -$0.21 misses by $0.04 . More news on: Chembio Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Previous 10 Next 10